leniolisib(CDZ 173)
99%
- Product Code: 101208
CAS:
1354690-24-6
| Molecular Weight: | 450.46 g./mol | Molecular Formula: | C₂₁H₂₅F₃N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Leniolisib (CDZ 173) is primarily used in the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare genetic disorder. It works by selectively inhibiting the PI3Kδ enzyme, which is overactive in APDS patients, helping to regulate immune system function and reduce symptoms such as recurrent infections, lymphoproliferation, and immune dysregulation. This targeted therapy offers a promising approach to managing the condition and improving the quality of life for affected individuals.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft130,689.93 |
+
-
|
| 0.025 | 10-20 days | Ft419,759.25 |
+
-
|
leniolisib(CDZ 173)
Leniolisib (CDZ 173) is primarily used in the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare genetic disorder. It works by selectively inhibiting the PI3Kδ enzyme, which is overactive in APDS patients, helping to regulate immune system function and reduce symptoms such as recurrent infections, lymphoproliferation, and immune dysregulation. This targeted therapy offers a promising approach to managing the condition and improving the quality of life for affected individuals.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :